A single-cell landscape of high-grade serous ovarian cancer

Benjamin Izar(Columbia University Irving Medical Center), Aviv Regev(Broad Institute), Julia Waldman(Broad Institute), Christopher Rodman(Broad Institute), Shaolin Mei(Harvard University), Parin Shah(Harvard University), Isaac Wakiro(Dana-Farber Cancer Institute), Abhay Kanodia(Dana-Farber Cancer Institute), Caroline Porter(Broad Institute), Orr Ashenberg(Broad Institute), Sébastien Vigneau(Broad Institute), Asaf Rotem(AstraZeneca (South Korea)), Johannes C. Melms(Columbia University Irving Medical Center), Rachel Leeson(Dana-Farber Cancer Institute), Idan Alter(Weizmann Institute of Science), Marcin Iwanicki(Stevens Institute of Technology), Bruce E. Johnson(Harvard University), Jia‐Ren Lin(Harvard University), Levi A. Garraway(Broad Institute), Ursula A. Matulonis(Dana-Farber Cancer Institute), Joyce F. Liu(Duke University), Meri Rogava(Columbia University Irving Medical Center), Elizabeth H. Stover(Dana-Farber Cancer Institute), Peter K. Sorger(Harvard University Press), Caitlin E. Mills(Harvard University), Orit Rozenblatt–Rosen(Broad Institute), Michael S. Cuoco(Broad Institute), Livnat Jerby‐Arnon(Broad Institute), Panagiotis A. Konstantinopoulos(Dana-Farber Cancer Institute), Michal Slyper(Broad Institute), Sarah R. Walker(Harvard University Press), Titus J. Brinker(German Cancer Research Center), Mei-Ju Su(Harvard University), Itay Tirosh(Weizmann Institute of Science)
Nature Medicine
June 22, 2020
Cited by 522


Related Papers